Press Releases
 
Competitive Landscape for Global Rare Metabolic Disorders Screening Market by Segments - 2024

Transparency Market Research Report Added "Rare Metabolic Disorders Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024"

, 21 April 2017 -- Rare metabolic disorders market can be divided into disorders of carbohydrate metabolism, disorder of protein metabolism, and others. Rare metabolic disorders are caused due genetic conditions which result in metabolism problems.

Rare metabolic disorders are caused due genetic conditions which result in metabolism problems. Defective gene present in individuals with metabolic disorder results in deficiency of essential enzymes. There are several types of metabolic disorders with varied symptoms, diagnosis, and treatments. Gene mutation is the leading cause of rare metabolic disorders. The mutated gene is passed from one generation to another generation. This type of genetic transmission is known as autosomal recessive inheritance. The incidence rate of rare metabolic disorder in newborn population is about 1 in 1,000 to 2,500. The rate of inheritance of rare metabolic disorders in ethnic population such as Jews of Central and Eastern Europe is much higher. Rare metabolic disorders can be divided into disorders of carbohydrate metabolism, disorder of protein metabolism, and others.

According to the European Federation of Pharmaceutical Industries and Associations, rare metabolic disorders such as Pompe’s disease affect approximately 5,000 to 10,000 people globally. Most affected babies die in their ?rst year of life. It is caused due to de?ciency of the enzyme acid maltase and leads severe muscle degeneration of the heart and the lung. Fabry’s disease is estimated to occur in approximately 1 in 40,000 births and affects around 5,000 people. It is caused due to deficiency of enzyme alpha-galactosidase A, and leads to progressive accumulation of lipids in the kidney, heart, and other organs.

Obtain Report Details @
http://www.transparencymarketresearch.com/rare-metabolic-disorders-screening-market.html

Inherited condition of type 1 mucopolysaccharidosis is another rare metabolic disorder affecting approximately 3,000 to 4,000 people globally. It is caused due alpha-L-iduronidase enzyme deficiency. Symptoms for this type of rare metabolic disorder are progressive damage to heart, lungs, liver, and kidneys, and in some cases neurological. The Hurler form is the most serious type which leads to severe neurological disorder, obstructive respiratory disease, and death before the age of ten. Scheie form, which is comparatively less severe, leads to corneal clouding, stiffness in joints, and heart disease.

Diagnosis of rare metabolic disorders is generally carried out through blood screening by measurement of metabolic products which accumulate in the blood stream and urine. The identification process of these metabolites is carried out by using sophisticated chromatographic equipment. The treatment of rare metabolic disorders is generally carried out using enzyme replacement therapy. On February 08, 2017, the FDA approved the first new born screening system for rare metabolic disorders (mucopolysaccharidosis type I, Pompe, Gaucher, and Fabry) “The Seeker System” by Baebies Inc. According to the U.S. Department of Health and Human Services, these disorders are observed in approximately 1 in 5,000 to 1 in 185,000 children.

Increasing awareness, rise in research activities in the field of proteomics and metabolomics, changing lifestyle, advancements in the health care industry, and technological advancement in biopharmaceuticals is expected to drive the rare metabolic disorder screening market during the forecast period. Rare metabolic disorder screening is gaining popularity among the new generation due to increasing awareness regarding genetic disorders which could prove to be life threatening. High cost of treatment, stringent government regulation, and unfavorable reimbursement act as restraints of the rare metabolic disorder screening market.

Geographically, the global rare metabolic disorder screening market has been segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America leads the global rare metabolic disease screening market because of increasing population, rising number of screening procedures, and technological advancements. It was closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for rare metabolic disorder disease screening primarily because of increasing health care expenditure in the region and growing awareness.

Key players in the global rare metabolic disorder screening market are Baebies, Inc., Shire plc, BioMarin, Actelion Pharmaceuticals Ltd., Sanofi, Pfizer, Inc., GlaxoSmithKline, and Amicus Therapeutics, Inc., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20792

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

# # #


Submitted by Sandy Researcher, Transparency Market Research on Friday, 21 April 2017 at 9:37 PM
Category: Health Care & Medical
 
Related News

Obtain 2007 runescape gold with Up To 10% Bonus on Rsorder for Fossil Island Until May 10
Monday, 24 Apr 2017

Emergency dental care in Los Angeles
Monday, 24 Apr 2017

Get The Best Cincinnati SEO & Digital Marketing Services To Boost Your Online Business
Sunday, 23 Apr 2017

Qherb Launches White Peony Extract For People to Prevent Cardiovascular Problems & Boost Immunity
Saturday, 22 Apr 2017

RxPhoto’s mobile medical photography platform impresses healthcare providers with V3 release
Saturday, 22 Apr 2017

Related Events

World Congress on Maternal Fetal Neonatal Medicine
Sunday, 23 Apr 2017

85th EAS Congress - European Atherosclerosis Society
Sunday, 23 Apr 2017

Radiology in Venice
Monday, 24 Apr 2017

6th Digital Marketing for Medical Devices West
Monday, 24 Apr 2017

Gene Therapy for Rare Disorders 2017
Monday, 24 Apr 2017

Latest News

Obtain 2007 runescape gold with Up To 10% Bonus on Rsorder for Fossil Island Until May 10
Monday, 24 Apr 2017

Gain runescape 3 gold with Up To 10% Bonus on Rsorder for Free XP Until May 10
Monday, 24 Apr 2017

TEPCO: Free Electrons Announces Cohort of 12 Energy Startups
Monday, 24 Apr 2017

www.unitedkingdominbusiness.co.uk offers great opportunities for free advertising strategies
Monday, 24 Apr 2017

Emergency dental care in Los Angeles
Monday, 24 Apr 2017

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2017
Today is Monday, 24 April 2017

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • How to backup files in your laptop
  • World Congress on Maternal Fetal Neonatal Medicine
  • 85th EAS Congress - European Atherosclerosis Society
  • Leveraging Customer Contact as a Strategic Asset: Customer Contact, East
  • Radiology in Venice

  • Latest Jobs
  • London Investment Property
  • We Are Hiring A Content Manager!